5 Key Takeaways
-
1
Occuity secured a £1.5 million Innovate UK grant to develop a handheld device for diabetes and pre-diabetes screening.
-
2
The SD1 device uses oculomics to assess diabetes risk through a non-contact scan of the eye, eliminating the need for blood samples.
-
3
The device measures advanced glycation end-products in the crystalline lens, which are linked to long-term glucose exposure.
-
4
Diabetes poses significant challenges for the NHS, being a leading cause of kidney failure, blindness, and amputations.
-
5
Occuity's SD1 aims to enhance early identification of pre-diabetes risk and improve access to screening in community settings.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
